Iperkalemia cronica nei pazienti cardio – renali: q & a per il cardionefrologo pratico

Luca Di Lullo; Claudio Ronco; Fulvio Floccari; Antonio De Pascalis; Vincenzo Barbera; Rodolfo Rivera; Antonio Bellasi

doi:10.33393/gcnd.2018.604

Authors

Luca Di Lullo UOC Nefrologia e Dialisi, Ospedale L. Parodi – Delfino, Colleferro, Italy
Claudio Ronco International Renal Research Institute, Ospedale S. Bortolo, Vicenza, Italy
Fulvio Floccari UOC Nefrologia e Dialisi, Ospedale “S. Paolo”, Civitavecchia, Italy
Antonio De Pascalis UOC Nefrologia e Dialisi, Ospedale “V. Fazzi”, Lecce, Italy
Vincenzo Barbera UOC Nefrologia e Dialisi, Ospedale L. Parodi – Delfino, Colleferro, Italy
Rodolfo Rivera Clinica Nefrologica, Ospedale “S.Gerardo”, Monza, Italy
Antonio Bellasi UOC Nefrologia e Dialisi, ASST Lariana, Ospedale S. Anna, Como, Italy

DOI:

https://doi.org/10.33393/gcnd.2018.604

Keywords:

Hyperkalemia, Chronic kidney disease, Heart failure, RAASi, Potassium-binder

Abstract

Chronic hyperkalemia is a serious medical condition often present in patients with chronic kidney disease (CKD) and heart failure (HF). It leads to poor outcomes and needs careful management by cardio-nephrologists. CKD, HF, diabetes and use of renin–angiotensin–aldosterone system inhibitors (RAASi) drugs are known to induce hyperkalemia. The current therapeutic options are not optimal as shown by the large number of CKD and HF patients suffering from hyperkalemia. The following review focuses on the main risk factors that lead to the development of hyperkalemia and provides a guide for the correct diagnosis and new approaches to therapy. (Cardionephrology)